Intel Corporation (INL.DE)
EUR 19.41
(-0.62%)
EUR 19.41
(-0.62%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 54.22 Billion | 63.05 Billion | 79.02 Billion | 77.86 Billion | 71.96 Billion | 70.84 Billion |
| Cost of Revenue | 32.51 Billion | 36.18 Billion | 35.2 Billion | 34.25 Billion | 29.82 Billion | 27.11 Billion |
| Gross Profit | 21.71 Billion | 26.86 Billion | 43.81 Billion | 43.61 Billion | 42.14 Billion | 43.73 Billion |
| Operating Expenses | 21.61 Billion | 24.53 Billion | 21.73 Billion | 19.73 Billion | 19.71 Billion | 20.49 Billion |
| Selling, General and Administrative Expenses | 5.63 Billion | 7 Billion | 6.54 Billion | 6.18 Billion | 6.15 Billion | 6.75 Billion |
| Research and Development Expenses | 16.04 Billion | 17.52 Billion | 15.19 Billion | 13.55 Billion | 13.36 Billion | 13.54 Billion |
| Other Expenses | -62 Million | - | - | -147 Million | 200 Million | 156 Million |
| Cost and Expenses | 54.13 Billion | 60.71 Billion | 56.94 Billion | 53.99 Billion | 49.53 Billion | 47.6 Billion |
| Operating Income | 93 Million | -1.93 Billion | 19.45 Billion | 23.67 Billion | 22.03 Billion | 23.31 Billion |
| Interest Expense | 878 Million | 496 Million | 597 Million | 504 Million | 489 Million | 468 Million |
| Income Tax Expense | -913 Million | -249 Million | 1.83 Billion | 4.17 Billion | 3.01 Billion | 2.26 Billion |
| Earnings before Tax | 762 Million | 7.76 Billion | 21.7 Billion | 25.07 Billion | 24.05 Billion | 23.31 Billion |
| Net Income | 1.68 Billion | 8.01 Billion | 19.86 Billion | 20.89 Billion | 21.04 Billion | 21.05 Billion |
| Earnings Per Share Basic | 0.40 | 1.95 | 4.89 | 4.98 | 4.77 | 4.57 |
| Earnings Per Share Diluted | 0.40 | 1.94 | 4.86 | 4.94 | 4.71 | 4.48 |
| Weighted Average Shares Outstanding | 4.19 Billion | 4.1 Billion | 4.05 Billion | 4.19 Billion | 4.41 Billion | 4.61 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.21 Billion | 4.12 Billion | 4.09 Billion | 4.23 Billion | 4.47 Billion | 4.7 Billion |
| Gross Margin | 0.40 | 0.43 | 0.55 | 0.56 | 0.59 | 0.62 |
| EBIT Margin | 0.21 | 0.18 | 0.46 | 0.49 | 0.47 | 0.33 |
| Profit Margin | 0.03 | 0.13 | 0.25 | 0.27 | 0.29 | 0.30 |
| EBITDA | 11.24 Billion | 11.1 Billion | 34.09 Billion | 37.94 Billion | 35.37 Billion | 32.87 Billion |
| Earnings Before Tax Margin | 0.00 | -0.03 | 0.25 | 0.30 | 0.31 | 0.33 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 12.83 Billion | 12.72 Billion | 15.4 Billion | 54.22 Billion | 14.15 Billion | 12.94 Billion |
| Cost of Revenue | 8.28 Billion | 7.5 Billion | 8.35 Billion | 32.51 Billion | 8.14 Billion | 8.31 Billion |
| Gross Profit | 4.54 Billion | 5.21 Billion | 7.04 Billion | 21.71 Billion | 6.01 Billion | 4.63 Billion |
| Operating Expenses | 5.56 Billion | 6 Billion | 5.6 Billion | 21.68 Billion | 5.21 Billion | 5.45 Billion |
| Selling, General and Administrative Expenses | 1.32 Billion | 1.55 Billion | 1.61 Billion | - | 1.34 Billion | 1.37 Billion |
| Research and Development Expenses | 4.23 Billion | 4.38 Billion | 3.98 Billion | - | 3.87 Billion | 4.08 Billion |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 13.85 Billion | 13.5 Billion | 13.96 Billion | 54.19 Billion | 13.35 Billion | 13.76 Billion |
| Operating Income | -1.96 Billion | -721 Million | 2.58 Billion | 93 Million | -8 Million | -1.01 Billion |
| Interest Expense | 294 Million | 258 Million | 267 Million | 878 Million | 204 Million | 214 Million |
| Income Tax Expense | -350 Million | 282 Million | 128 Million | -913 Million | -362 Million | -2.28 Billion |
| Earnings before Tax | -2 Billion | -719 Million | 2.78 Billion | 762 Million | -52 Million | -816 Million |
| Net Income | -1.61 Billion | -381 Million | 2.66 Billion | 1.68 Billion | 297 Million | 1.48 Billion |
| Earnings Per Share Basic | -0.38 | -0.09 | 0.57 | - | 0.07 | 0.35 |
| Earnings Per Share Diluted | -0.38 | -0.09 | 0.57 | - | 0.07 | 0.35 |
| Weighted Average Shares Outstanding | 4.26 Billion | 4.24 Billion | 4.22 Billion | 4.19 Billion | 4.2 Billion | 4.18 Billion |
| Weighted Average Shares Outstanding (Diluted) | 4.26 Billion | 4.24 Billion | 4.26 Billion | 4.21 Billion | 4.22 Billion | 4.19 Billion |
| Gross Margin | 0.35 | 0.41 | 0.46 | 0.40 | 0.43 | 0.36 |
| EBIT Margin | 0.15 | 0.14 | 0.28 | - | 0.30 | 0.13 |
| Profit Margin | -0.13 | -0.03 | 0.17 | 0.03 | 0.02 | 0.11 |
| EBITDA | 1.92 Billion | 1.83 Billion | 4.34 Billion | - | 4.26 Billion | 1.68 Billion |
| Earnings Before Tax Margin | -0.15 | -0.06 | 0.17 | 0.00 | -0.00 | -0.08 |
SOLB
SMSPHARMA
002255
000953
NOKBF
FCAP